Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
Open Access
- 19 July 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 105 (5), 628-639
- https://doi.org/10.1038/bjc.2011.240
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neckBritish Journal of Cancer, 2011
- Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspectiveDrug Resistance Updates, 2010
- Clinical Radiation Sensitivity With DNA Repair Disorders: An OverviewInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Systemic effects of local radiotherapyThe Lancet Oncology, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Identification and Biological Evaluation of a Novel and Potent Small Molecule Radiation Sensitizer via an Unbiased Screen of a Chemical LibraryCancer Research, 2007
- Identity tests: determination of cell line cross-contaminationCytotechnology, 2006
- Approaches for the sequence-specific knockdown of mRNANature Biotechnology, 2003
- The Hallmarks of CancerCell, 2000
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990